Jui‐Ling Hsu

785 citations

30 papers · 551 indexed · h-index 15

Impact in

Pharmacology top 10%
- Berberine and alkaloids research
- Alkaloids: synthesis and pharmacology
Cancer Research
- Cancer, Hypoxia, and Metabolism
- Synthesis and Biological Activity

Papers in ⓘ

Toxicology 3
- Bioactive Compounds and Antitumor Agents 3
Molecular Biology 29
- PI3K/AKT/mTOR signaling in cancer 5
- Ubiquitin and proteasome pathways 5
- Cancer therapeutics and mechanisms 4
- DNA Repair Mechanisms 4
- Protein Degradation and Inhibitors 3
- ATP Synthase and ATPases Research 3

Co-authors: Jih‐Hwa Guh (26 shared papers)Lih‐Ching Hsu (19 shared papers)Fen‐Pi Chou (3 shared papers)Chau‐Jong Wang (3 shared papers)Yih‐Shou Hsieh (1 shared paper)Yunn‐Fang Ho (4 shared papers)Shun‐Chieh Young (2 shared papers)Shih‐Ping Liu (5 shared papers)
Journals: The Prostate (5 papers)Frontiers in Pharmacology (4 papers)Naunyn-Schmiedeberg s Archives of Pharmacology (3 papers)Molecules (2 papers)Toxicology and Applied Pharmacology (2 papers)
Partner nations: Taiwan United States China

In The Last Decade

Jui‐Ling Hsu

29 papers receiving 543 citations

Peers

Countries citing papers authored by Jui‐Ling Hsu

Since Specialization

Citations

This map shows the geographic impact of Jui‐Ling Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jui‐Ling Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jui‐Ling Hsu more than expected).

Fields of papers citing papers by Jui‐Ling Hsu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jui‐Ling Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jui‐Ling Hsu. The network helps show where Jui‐Ling Hsu may publish in the future.

Co-authors

The 25 scholars most cited alongside Jui‐Ling Hsu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jui‐Ling Hsu Line = papers co-authored together Jui‐Ling Hsu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Inhibitory effect of berberine on the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2 Toxicology and Applied Pharmacology ·Pei-Ling Peng, Yih‐Shou Hsieh, Chau‐Jong Wang, Jui‐Ling Hsu, Fen‐Pi Chou	2006	134
2	The Combination of MK-2206 and WZB117 Exerts a Synergistic Cytotoxic Effect Against Breast Cancer Cells Frontiers in Pharmacology ·Yuliang Li, Hao‐Cheng Weng, Jui‐Ling Hsu, Shu‐Wha Lin, Jih‐Hwa Guh, Lih‐Ching Hsu	2019	37
3	Tunicamycin induces resistance to camptothecin and etoposide in human hepatocellular carcinoma cells: role of cell-cycle arrest and GRP78 Naunyn-Schmiedeberg s Archives of Pharmacology ·Jui‐Ling Hsu, Po‐Cheng Chiang, Jih‐Hwa Guh	2009	31
4	Terfenadine induces anti-proliferative and apoptotic activities in human hormone-refractory prostate cancer through histamine receptor-independent Mcl-1 cleavage and Bak up-regulation Naunyn-Schmiedeberg s Archives of Pharmacology ·Wei‐Ting Wang, Yen‐Hui Chen, Jui‐Ling Hsu, Wohn‐Jenn Leu, Chia‐Chun Yu, She‐Hung Chan, Yunn‐Fang Ho, Lih‐Ching Hsu, Jih‐Hwa Guh	2013	31
5	Evaluation of the Anticancer Activity of a Bile Acid-Dihydroartemisinin Hybrid Ursodeoxycholic-Dihydroartemisinin in Hepatocellular Carcinoma Cells Frontiers in Pharmacology ·Tzu‐En Huang, Yi-Ning Deng, Jui‐Ling Hsu, Wohn‐Jenn Leu, Elena Marchesi, Massimo L. Capobianco, Paolo Marchetti, Maria Luisa Navacchia, Jih‐Hwa Guh, Daniela Perrone, Lih‐Ching Hsu	2020	30
6	Protection effect of piper betel leaf extract against carbon tetrachloride-induced liver fibrosis in rats Archives of Toxicology ·Shun‐Chieh Young, Chau‐Jong Wang, Jingjing Lin, Pei-Ling Peng, Jui‐Ling Hsu, Fen‐Pi Chou	2006	29
7	Ardisianone, a natural benzoquinone, efficiently induces apoptosis in human hormone‐refractory prostate cancers through mitochondrial damage stress and survivin downregulation The Prostate ·Chia‐Chun Yu, Ping‐Jung Wu, Jui‐Ling Hsu, Yunn‐Fang Ho, Lih‐Ching Hsu, Yu‐Jia Chang, Hsun‐Shuo Chang, Ih‐Sheng Chen, Jih‐Hwa Guh	2012	26
8	Reevesioside A, a Cardenolide Glycoside, Induces Anticancer Activity against Human Hormone-Refractory Prostate Cancers through Suppression of c-myc Expression and Induction of G1 Arrest of the Cell Cycle PLoS ONE ·Wohn‐Jenn Leu, Hsun‐Shuo Chang, She‐Hung Chan, Jui‐Ling Hsu, Chia‐Chun Yu, Lih‐Ching Hsu, Ih‐Sheng Chen, Jih‐Hwa Guh	2014	25
9	Increased sensitivity of Hep G2 cells toward the cytotoxicity of cisplatin by the treatment of piper betel leaf extract Archives of Toxicology ·Shun‐Chieh Young, Chau‐Jong Wang, Jeng‐Dong Hsu, Jui‐Ling Hsu, Fen‐Pi Chou	2005	23
10	Phosphodiesterase Type 5 Inhibitors Synergize Vincristine in Killing Castration-Resistant Prostate Cancer Through Amplifying Mitotic Arrest Signaling Frontiers in Oncology ·Jui‐Ling Hsu, Wohn‐Jenn Leu, Lih‐Ching Hsu, Chen‐Hsun Ho, Shih‐Ping Liu, Jih‐Hwa Guh	2020	21
11	Pim-1 knockdown potentiates paclitaxel-induced apoptosis in human hormone-refractory prostate cancers through inhibition of NHEJ DNA repair Cancer Letters ·Jui‐Ling Hsu, Pui-Kei Leong, Yunn‐Fang Ho, Lih‐Ching Hsu, Pin‐Hsuan Lu, Ching‐Shih Chen, Jih‐Hwa Guh	2012	19
12	Phosphodiesterase Type 5 (PDE5) Inhibitors Sensitize Topoisomerase II Inhibitors in Killing Prostate Cancer Through PDE5-Independent Impairment of HR and NHEJ DNA Repair Systems Frontiers in Oncology ·Jo‐Fan Chang, Jui‐Ling Hsu, Yi-Hua Sheng, Wohn‐Jenn Leu, Chia‐Chun Yu, She‐Hung Chan, Mei‐Ling Chan, Lih‐Ching Hsu, Shih‐Ping Liu, Jih‐Hwa Guh	2019	18
13	Rottlerin potentiates camptothecin-induced cytotoxicity in human hormone refractory prostate cancers through increased formation and stabilization of topoisomerase I-DNA cleavage complexes in a PKCδ-independent pathway Biochemical Pharmacology ·Jui‐Ling Hsu, Yunn‐Fang Ho, Tsai‐Kun Li, Ching‐Shih Chen, Lih‐Ching Hsu, Jih‐Hwa Guh	2012	17
14	The Combination of a Novel GLUT1 Inhibitor and Cisplatin Synergistically Inhibits Breast Cancer Cell Growth By Enhancing the DNA Damaging Effect and Modulating the Akt/mTOR and MAPK Signaling Pathways Frontiers in Pharmacology ·Hao‐Cheng Weng, Chieh‐Ju Sung, Jui‐Ling Hsu, Wohn‐Jenn Leu, Jih‐Hwa Guh, Fan‐Lu Kung, Lih‐Ching Hsu	2022	16
15	Para-Toluenesulfonamide Induces Anti-tumor Activity Through Akt-Dependent and -Independent mTOR/p70S6K Pathway: Roles of Lipid Raft and Cholesterol Contents Frontiers in Pharmacology ·Jui‐Ling Hsu, Wohn‐Jenn Leu, Lih‐Ching Hsu, Shih‐Ping Liu, Nanshan Zhong, Jih‐Hwa Guh	2018	14
16	ICAM-1 and AMPK regulate cell detachment and apoptosis by N-methyl-N′-nitro-N-nitrosoguanidine, a widely spread environmental chemical, in human hormone-refractory prostate cancers Toxicology and Applied Pharmacology ·Yi-Cheng Chen, Pin‐Hsuan Lu, Jui‐Ling Hsu, Chia‐Chun Yu, Jih‐Hwa Guh	2011	9
17	Ascleposide, a natural cardenolide, induces anticancer signaling in human castration‐resistant prostatic cancer through Na⁺/K⁺‐ATPase internalization and tubulin acetylation The Prostate ·Wohn‐Jenn Leu, Ching‐Ting Wang, Jui‐Ling Hsu, Ih‐Sheng Chen, Hsun‐Shuo Chang, Jih‐Hwa Guh	2020	9
18	Chalcones Display Anti-NLRP3 Inflammasome Activity in Macrophages through Inhibition of Both Priming and Activation Steps—Structure-Activity-Relationship and Mechanism Studies Molecules ·Wohn‐Jenn Leu, Jung-Chun Chu, Jui‐Ling Hsu, Chimin Du, Yi‐Huei Jiang, Lih‐Ching Hsu, Wei‐Jan Huang, Jih‐Hwa Guh	2020	9
19	Epi-reevesioside F inhibits Na+/K+-ATPase, causing cytosolic acidification, Bak activation and apoptosis in glioblastoma Oncotarget ·Jui‐Ling Hsu, Fan-Lun Liu, Lih‐Ching Hsu, Hsun‐Shuo Chang, Wohn‐Jenn Leu, Chia‐Chun Yu, Wei‐Ling Chang, Ih‐Sheng Chen, Fan‐Lu Kung, Jih‐Hwa Guh	2015	9
20	Enantiomerically pure β-dipeptide derivative induces anticancer activity against human hormone-refractory prostate cancer through both PI3K/Akt-dependent and -independent pathways Oncotarget ·Mei‐Ling Chan, Chia‐Chun Yu, Jui‐Ling Hsu, Wohn‐Jenn Leu, She‐Hung Chan, Lih‐Ching Hsu, Shih‐Ping Liu, Polina M. Ivantcova, Özdemir Doğan, Stefan Bräse, Konstantin V. Kudryavtsev, Jih‐Hwa Guh	2017	8

About Jui‐Ling Hsu

Jui‐Ling Hsu is a scholar working on Toxicology, Molecular Biology, Biotechnology, Cancer Research and Oncology, having authored 30 papers that have together received 551 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (5 papers), Ubiquitin and proteasome pathways (5 papers), Cancer therapeutics and mechanisms (4 papers), DNA Repair Mechanisms (4 papers), Drug Transport and Resistance Mechanisms (4 papers), Protein Degradation and Inhibitors (3 papers), ATP Synthase and ATPases Research (3 papers) and Bioactive Compounds and Antitumor Agents (3 papers). The work is most often cited by research in Pharmacology (73 citations), Cancer Research (117 citations), Toxicology (26 citations), Pharmacology (125 citations) and Molecular Biology (325 citations). Jui‐Ling Hsu has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Jih‐Hwa Guh, Lih‐Ching Hsu, Fen‐Pi Chou, Chau‐Jong Wang, Yih‐Shou Hsieh, Yunn‐Fang Ho, Shun‐Chieh Young, Shih‐Ping Liu, Hsun‐Shuo Chang and She‐Hung Chan. Their work appears in journals such as The Prostate, Frontiers in Pharmacology, Naunyn-Schmiedeberg s Archives of Pharmacology, Molecules and Toxicology and Applied Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact